Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Blended cognitive behaviour therapy (bCBT) is an effective treatment for fear of cancer recurrence (FCR) in curatively-treated breast, colorectal and prostate cancer survivors with high FCR. However, long-term outcomes are unknown. This study investigated the long-term efficacy and cost-effectiveness of bCBT compared with care as usual (CAU). METHODS: Eighty-eight cancer survivors with high FCR (Cancer Worry Scale ≥14) were randomly assigned to bCBT (n = 45) or CAU (n = 43). Data were collected at baseline and at three, nine and fifteen months from baseline and analysed by modified intention-to-treat. Efficacy was investigated with linear mixed-effects models. Cost-effectiveness was investigated from a societal perspective by comparing costs with quality-adjusted life-years (QALYs). RESULTS: Participants who received bCBT reported significantly lower FCR compared with CAU (mean difference of - 1.787 [95% CI -3.251 to - 0.323, p = 0.017] at 15 months follow-up), and proportionally greater self-rated and clinically significant improvement at each follow-up measurement. Total QALYs were non-significantly different between conditions when adjusted for utility score baseline differences (0.984 compared to 0.957, p = 0.385), while total costs were €631 lower (95% CI -1737 to 2794, p = 0.587). Intervention costs of bCBT were €466. The incremental cost-effectiveness ratio amounted to an additional €2049 per QALY gained, with a 62% probability that bCBT is cost-effective at a willingness to pay (WTP) threshold of €20,000 per QALY. Results were confirmed in sensitivity analyses. CONCLUSIONS: bCBT for cancer survivors with FCR is clinically and statistically more effective than CAU on the long-term. In addition, bCBT is a relatively inexpensive intervention with similar costs and QALYs as CAU. TRIAL REGISTRATION: The RCT was registered in the Dutch National Trial Register ( NTR4423 ) on 12-Feb-2014. This abstract was previously presented at the International Psycho-Oncology Society conference of 2018 and published online. (Psycho-oncology, 27(S3):8-55; 2018).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SWORD study found to significantly reduce long-term (15 weeks) FCR [37, 38].”
From Web-based interventions for fear of cancer recurrence: A scoping review with a focus on suggestions for the development and evaluation of future interventions (2024) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139 · cited 1×
“Secondary outcomes were FCR severity (Fear of Cancer Recurrence Inventory [FCRI] severity subscale) [30], cancer-specific distress (Impact of Events Scale [IES]) [31, 32], distress (Hospital Anxiety and Depression Scale [HADS]) [33], fatigue (Checklist Individual Strength 8R [CIS-8R]) [34], and health-related quality…”
MethodAaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005 · cited 1×
“Secondary outcomes were FCR severity (Fear of Cancer Recurrence Inventory [FCRI] severity subscale) [30], cancer-specific distress (Impact of Events Scale [IES]) [31, 32], distress (Hospital Anxiety and Depression Scale [HADS]) [33], fatigue (Checklist Individual Strength 8R [CIS-8R]) [34], and health-related quality…”
MethodEuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736 · cited 1×
“To calculate QALYs, utility scores were obtained by using the EuroQol five dimensions three-level questionnaire (EQ-5D-3 L) and by applying the Dutch EQ-5D tariff [36, 37].”
MethodDepression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Impact of Event Scale: A Measure of Subjective Stress
Horowitz, M., Wilner, N., & Alvarez, W. (1979) · Psychosomatic Medicine · doi:10.1097/00006842-197905000-00004 · Cited by 7,813 · cited 1×
“Secondary outcomes were FCR severity (Fear of Cancer Recurrence Inventory [FCRI] severity subscale) [30], cancer-specific distress (Impact of Events Scale [IES]) [31, 32], distress (Hospital Anxiety and Depression Scale [HADS]) [33], fatigue (Checklist Individual Strength 8R [CIS-8R]) [34], and health-related quality…”
MethodJacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770 · cited 1×
“96) [41] and a decrease of CWS scores to the normal range (clinically significant change, CWS < 14) [27].”
BackgroundInternet-based cognitive behaviour therapy for symptoms of depression and anxiety: A meta-analysis
SPEK, V., CUIJPERS, P., NYKLÍČEK, I., RIPER, H., KEYZER, J., & POP, V. (2007) · Psychological Medicine · doi:10.1017/s0033291706008944 · Cited by 1,586
Multiple imputation in health‐are databases: An overview and some applications
Rubin, D. B., & Schenker, N. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100410 · Cited by 1,550 · cited 1×
“Twenty imputed datasets were created and pooled according to Rubin’s rules [44].”
MethodAndrews, G., Cuijpers, P., Craske, M. G., McEvoy, P., & Titov, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013196 · Cited by 1,311
Research works printed but not linked: 1
- Humphris G, Rogers S. AFTER and beyond: cancer recurrence fears and a test of an intervention in oral and oropharyngeal patients. Soc Sci Dent. 2012;2:29–38.
Cited by
Williams, J. T. W., Pearce, A., & Smith, A. '. (2021) · Psycho-Oncology · doi:10.1002/pon.5673 · Cited by 95
“Three studies conducted a cost‐utility analysis (CUA) and reported the ICER per quality‐adjusted life year (QALY) gained.(32,34,35) QALYs were measured using the AQol‐8D(32,35) or EQ‐5D‐3L.”
MethodInfluentialLyu, M., Siah, R. C., Lam, A. S. L., & Cheng, K. K. F. (2022) · Journal of Advanced Nursing · doi:10.1111/jan.15321 · Cited by 77
Hardiman, K. M., Felder, S. I., Friedman, G., Migaly, J., Paquette, I. M., & Feingold, D. L. (2021) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000001984 · Cited by 82
van Beek, F. E., Wijnhoven, L. M. A., Holtmaat, K., Custers, J. A. E., Prins, J. B., Leeuw, I. M. V., & Jansen, F. (2021) · Psycho-Oncology · doi:10.1002/pon.5753 · Cited by 70
Self-citationPark, S.-Y., & Lim, J.-W. (2022) · BMC Cancer · doi:10.1186/s12885-021-08909-y · Cited by 53
“Although the theoretical foundations, formats and delivery methods of these interventions differ, the available interventions are based on CBT [25].”
Background
Metadata
- Authors
- Burm, R., Thewes, B., Rodwell, L., Kievit, W., Speckens, A., van de Wal, M., & Prins, J.
- Affiliations
- Radboud University Medical Center (NL)
- Corresponding author
- Burm, Rens
- Venue
- BMC Cancer
- Published
- 2019-05-16
- Volume
- 19
- Issue
- 1
- Pages
- 462-462
- ISSN
- 1471-2407 (ISSN-L)
- PMC
- PMC6524293
- OpenAlex
- W2947157965
- Cited by
- 55
- References
- 59
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 9 · 2023: 7 · 2022: 13 · 2021: 9 · 2020: 3 · 2019: 2
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- BMC Cancer (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- KWF Kankerbestrijding (KUN 2012–5545)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Keywords
- fear of cancer recurrence, cancer survivors, breast cancer, prostate cancer, colorectal cancer, long-term efficacy, cost-effectiveness, quality-adjusted life years, incremental cost-effectiveness ratio, psycho-oncology, intervention costs, willingness-to-pay threshold, societal perspective
- MeSH terms
- Cancer Survivors, Aged, Breast Neoplasms, Cost-Benefit Analysis, Fear, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Cognitive Behavioral Therapy, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial. https://app.cochat.ai/papers/10.1186/s12885-019-5615-3
- The paper
- Burm, R., Thewes, B., Rodwell, L., Kievit, W., Speckens, A., van de Wal, M., & Prins, J. (2019). Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial. BMC Cancer. https://doi.org/10.1186/s12885-019-5615-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.